Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models
Compose a Response to This Article
Other responses
No responses have been published for this article.
